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Does chemical cross-linking with NHS esters reflect the
chemical equilibrium of protein-protein noncovalent interactions
in solution?
Abstract
Chemical cross-linking in combination with matrix-assisted laser desorption/ionization mass
spectrometry (MALDI-MS) has emerged as a powerful tool to study non-covalent protein complexes.
Nevertheless, there are still many questions to answer: Does the amount of detected cross-linked
complex correlate with the amount of protein complex in solution? In which concentration and affinity
range is specific cross-linking possible? In order to answer these questions, we performed systematic
cross-linking studies with two complexes using the N8 hydroxysuccinimidyl ester disuccinimidyl
suberate (DSS): i) NCoA-1 and mutants of the interacting peptide STAT6Y, covering a KD range of 30
nM to > 25 μM and ii) α-thrombin and basic pancreatic trypsin inhibitor (BPTI), which shows a buffer
dependent KD value between 100 and 320 μM. Samples were analyzed by MALDI-MS. For
NCoA-1•STAT6Y, a good correlation of the amount of cross-linked species with the calculated fraction
of complex present in solution was observed. Thus, chemical cross-linking in combination with
MALDI-MS can be used to rank binding affinities. The specificity of complex formation for the
mid-affinity range up to about KD ≈ 25 μM could be proven by comparing against a non-binding
peptide and by studying the concentration dependence. In order to study in which affinity range specific
cross-linking can be applied, the weak α-thrombin•BPTI complex was investigated. Although variations
of the sodium concentration can change the dissociation constant up to 3-fold for this interaction, no
significant effect on the amount of detected complex was observed at different peptide concentrations.
Our interpretation of this result is that the detected complex is not specific, but a nonspecifically
cross-linked species. Consequently, chemical cross-linking is not applicable to low-affinity complexes
with KD >> 25 μM with the experimental approach used in this study.
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Abstract:  1 
Chemical cross-linking in combination with matrix-assisted laser desorption/ionization 2 
mass spectrometry (MALDI-MS) has emerged as a powerful tool to study non-covalent protein 3 
complexes. Nevertheless, there are still many questions to answer: Does the amount of detected 4 
cross-linked complex correlate with the amount of protein complex in solution? In which 5 
concentration and affinity range is specific cross-linking possible? In order to answer these 6 
questions, we performed systematic cross-linking studies with two complexes using the N-7 
hydroxysuccinimidyl ester disuccinimidyl suberate (DSS): i) NCoA-1 and mutants of the 8 
interacting peptide STAT6Y, covering a KD range of 30 nM to > 25 μM and ii) α-thrombin and 9 
basic pancreatic trypsin inhibitor (BPTI), which shows a buffer dependent KD value between 100 10 
and 320 µM. Samples were analyzed by MALDI-MS. For NCoA-1•STAT6Y, a good correlation 11 
of the amount of cross-linked species with the calculated fraction of complex present in solution 12 
was observed. Thus, chemical cross-linking in combination with MALDI-MS can be used to 13 
rank binding affinities. The specificity of complex formation for the mid-affinity range up to 14 
about KD ≈ 25 μM could be proven by comparing against a non-binding peptide and by studying 15 
the concentration dependence. In order to study in which affinity range specific cross-linking can 16 
be applied, the weak α-thrombin•BPTI complex was investigated. Although variations of the 17 
sodium concentration can change the dissociation constant up to 3-fold for this interaction, no 18 
significant effect on the amount of detected complex was observed at different peptide 19 
concentrations. Our interpretation of this result is that the detected complex is not specific, but a 20 
nonspecifically cross-linked species. Consequently, chemical cross-linking is not applicable to 21 
low-affinity complexes with KD >> 25 μM with the experimental approach used in this study. 22 
23 
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Introduction 1 
The identification and quantitation of protein-protein interactions is the basis for 2 
understanding most cellular pathways. Numerous analytical techniques have been developed to 3 
gain insight into biochemical communication between proteins, such as circular dichroism 4 
spectroscopy (CD), isothermal titration calorimetry (ITC), nuclear magnetic resonance 5 
spectroscopy (NMR), surface plasmon resonance (SPR), light scattering, gel filtration, or 6 
fluorescence polarization assay (FPA) to name just a few. The ideal method would yield the 7 
stoichiometry and size of a complex, as well as its thermodynamic and kinetic data, and would 8 
allow differentiating between specific and nonspecific interactions for a broad affinity range. 9 
Physiologically relevant interactions have dissociation constants (KD) between 10-16 and 10-3 M, 10 
making high demands on a detection method. [1, 2]  11 
Chemical cross-linking can stabilize non-covalent complexes, prevents their dissociation, 12 
and thus allows rapid identification of interactions and determination of complex stoichiometry 13 
and mass by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) with 14 
minimal sample consumption. [3, 4] During MALDI ionization, most of the species present in 15 
the sample appear as singly charged pseudo-molecular ions in the spectra, greatly simplifying the 16 
data interpretation for complex mixtures. In combination with novel detector technologies, the 17 
mass range has been significantly extended to more than 1 MDa, allowing sensitive detection of, 18 
for example, immunocomplexes or protein multimers. [5, 6] Among the most common cross-19 
linking agents are homobifunctional N-hydroxy succinimide (NHS) esters, which were 20 
introduced as highly amine-reactive more than 30 years ago. [7] The chemical cross-linking step 21 
relies upon an acylation of nucleophilic residues, namely amines of lysine or the N-terminus, and 22 
hydroxyl side chains of serine, threonine or tyrosine [8, 9], which are accessible on the exterior 23 
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surface of the proteins. The use of high protein concentrations increases the probability of 1 
unintentionally forming cross-linked protein multimers as a consequence of nonspecific 2 
encounters. Analysis of complexes after chemical cross-linking by MALDI-MS does not yield 3 
the occupancy of a specific binding site. Thus, this analytical strategy is possibly susceptible to 4 
nonspecific binding. 5 
The specificity of chemical cross-linking with NHS esters has been demonstrated in the 6 
lower µM concentration range using immunocomplexes. [5, 10] Only specific interactions were 7 
found to undergo chemical cross-linking. For example, Nazabal et al. showed that incubation of 8 
human and bovine serum albumins with anti-human serum albumin and an NHS cross-linker 9 
yielded only for the mixture containing human serum albumin a significant antibody-antigen 10 
complex peak in the MALDI mass spectra. [5] Similarly, sandwich assays of bovine prion 11 
protein containing two different monoclonal antibodies were only detected for antibodies known 12 
to interact with the antigen, but not for anti-glutathione-S-transferase. [10] As demonstrated for 13 
complexes containing the peptide bradykinin and the corresponding B2 receptor, the application 14 
of chemical cross-linking with homobifunctional NHS esters is limited by the availability of 15 
reactive amino acids. [11] For the given example, the lack of accessible lysine residues close to 16 
the binding domain increased the fraction of nonspecific cross-linking. Specific cross-linking 17 
was achieved by using heterobifunctional reagents containing maleimide and NHS functionality. 18 
Previous research papers indicated that chemical cross-linking has also the potential to 19 
differentiate between low- and high-affinity complexes. In studies on the functional epitope of 20 
the urokinase-type plasminogen activator receptor (uPAR) for the interaction with the growth 21 
factor-like module of urokinase-type plasminogen activator (uPA), alanine mutants of the amino-22 
terminal fragment of uPA (ATF) with dissociation constants in the low to high nanomolar range 23 
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were subjected to chemical cross-linking with uPAR using disuccinimidyl suberate (DSS). After 1 
analysis of the radioactively labeled and cross-linked samples by SDS-PAGE and 2 
autoradiography, a semiquantitative correlation of complex levels with kinetic data obtained by 3 
surface plasmon resonance was observed giving no indication on its absolute agreement. [12, 13] 4 
A semiquantitative correlation with solution phase was also observed for the binding of a 5 
coactivator peptide (SRC1) to the human estrogen receptor α ligand binding domain (hERα 6 
LBD) upon interaction with different small-molecule ligands by chemical cross-linking with 7 
NHS esters and MALDI-MS detection. Complex detection only in the presence of an agonist 8 
ligand was confirmed with native nano-electrospray ionization MS (nanoESI-MS). [14]  9 
So far, chemical cross-linking with NHS esters has mainly been applied to high-affinity 10 
protein-protein complexes with dissociation constants in the picomolar or low nanomolar range, 11 
such as human serum albumin and its corresponding antibody [5, 15] or calmodulin•melittin 12 
[16]. Only few studies report about cross-linking of lower affinity complexes. For example, in 13 
the case of the CRT(189–88)•ERp57 complex, chemical cross-linking was used to confirm the 14 
interaction with KD = 9.1  3.0 M. [17] The authors are not aware of any study featuring 15 
chemical cross-linking of low-affinity complexes with dissociation constants in the high 16 
micromolar range or investigations dealing with the application range (in terms of KD) for 17 
specific cross-linking. This work addresses the affinity dependence and the concentration range 18 
of specific chemical cross-linking with NHS esters.  19 
A reference system of the nuclear receptor coactivator NCoA-1 PAS B domain and the 20 
transactivation domain of the signal transducer and activator of transcription 6 (STAT6) was 21 
chosen. The complex formation is mediated by the hydrophobic face of the C-terminal domain of 22 
STAT6 with the -helical recognition motif LXXLL (where L is leucine and X any amino acid). 23 
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[18] In Fig. 1, a ribbon diagram of NCoA-1 (V259-E367) complexed with a STAT6 derived 1 
peptide (L795-E808) is shown (PDB ID code 1OJ5). Potentially cross-linkable lysines close to 2 
the binding pocket are highlighted. Assuming a coupling of the cross-linker to the -amino 3 
group of L794 (not included in 1OJ5) or K804 of the STAT6 peptide, the lysines K265 and K271 4 
of NCoA-1 should be well within reach for the hydrophobic cross-linker DSS, which has a 5 
spacer arm capable of bridging N-N distances of 5.58 to 11.42 Å. [19] 6 
NCoA-1 (257-385) complexes with alanine or cyclohexyl alanine mutants of STAT6 7 
(L794-G814) derived peptides had been investigated previously, to derive their binding affinity 8 
by a competitive FPA. The resulting KDs cover three orders of magnitude (KD = 0.03  9 
0.015 M to KD = 13.3  0.6 M); some mutations essentially abolished the interaction with 10 
NCoA-1 (KD > 25 M). [20] Six different mutants were selected based on their binding affinities 11 
with NCoA-1. The main emphasis was to cover a wide range of binding affinities in order to 12 
investigate a possible correlation between the fraction of complex present in solution and that 13 
detected by chemical cross-linking and MALDI-MS. With the intention of extending the range of 14 
KDs to above 25 μM for this study, a low-affinity complex, α-Thromin and basic pancreatic 15 
trypsin inhibitor (BPTI) with a buffer dependent KD (100 to 320 M) was selected and 16 
chemically cross-linked under different conditions. [21] 17 
 18 
Materials and Methods 19 
Materials. The nuclear receptor coactivator NCoA-1 PAS B domain (residues 257-385 of human 20 
NCoA-1, Mw = 15 kDa) obtained analogous to [20] was dialyzed against a phosphate buffer (10 21 
mM Na2HPO4/NaH2PO4/150 mM NaCl, pH 8.0) and the resulting 70-µM-solution was diluted to 22 
10 to 30 µM. Alanine (A) or cyclohexylalanine (Cha) mutants of a linear peptide containing 23 
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STAT6 residues L794 to G814 (Mw = 2.4 kDa) were obtained by solid-phase peptide synthesis 1 
as described previously [20], dissolved in Milli-Q water (Millipore, Molsheim, France), and 2 
diluted to 10 to 30 µM in the same phosphate buffer. The STAT6 derived peptide contained a C-3 
terminal tyrosine to aid concentration measurements by UV (STAT6Y). Oxidized bovine insulin 4 
chain A, basic pancreatic trypsin inhibitor (BPTI) and -thrombin were obtained from Sigma-5 
Aldrich Chemie GmbH (Buchs, Switzerland). All peptide and protein concentrations were 6 
determined by UV-absorption at 280 nm using a NanoDrop 1000 (Thermo Fisher Scientific, 7 
Wilmington, USA). 8 
The cross-linker DSS was obtained from Pierce (Rockford, USA) and sinapinic acid from 9 
Sigma-Aldrich. All commercial solvents and reagents were obtained in the highest available 10 
purity and used without additional purification.  11 
 12 
Chemical Cross-linking. For experiments with the NCoA-1•STAT6Y complex, 10 µL of 10 µM 13 
NCoA-1 protein solution were incubated with 10 µL of 10 µM peptide solution for 10 min at 14 
2°C. In order to investigate the concentration dependence, 10 µL of 10, 20 or 30 µM coactivator 15 
protein solution were incubated with equimolar amounts of peptides mutated at position 794, 796 16 
or 797, respectively. For negative controls, 10 µL of 10, 20, 30 or 70 µM coactivator protein 17 
solution were incubated with equimolar amounts of the non-binding peptide oxidized bovine 18 
insulin chain A. 10 µL of the solution were mixed with a 50-fold molar excess of DSS for 4 h at 19 
2…8 °C in a 10/1 (v/v) ratio. The remaining solution was treated as a control and 1 µL of DMF 20 
was added. Both, control and reaction solution were quenched with 5 µL of 50 mM NH4HCO3 21 
solution and afterwards purified by ZipTip (0,6 µL C4 resin, Millipore, Molsheim, France). For 22 
experiments with final protein concentrations exceeding 5 µM, the reaction mixtures and control 23 
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samples were diluted to reach a final protein concentration comparable to the concentrations of 1 
the first experiment prior to ZipTip. In the case of the α-thrombin•BPTI complex, α-thrombin 2 
with a final protein concentration of about 20 µM was incubated with an equimolar amount or an 3 
2- to 5-fold molar excess of BPTI in different buffers (10 mM Na2HPO4/NaH2PO4 at pH 8.0 with 4 
no additional salt, 145 mM tetramethylammonium chloride/5 mM NaCl or 150 mM NaCl) for 15 5 
min. 9 µL of the solution were mixed with a 30-fold molar excess of DSS in a 10/1 (v/v) ratio at 6 
room temperature for different reaction times. No purification was applied.  7 
 8 
Mass spectrometric detection. Two commercial MALDI-ToF mass spectrometers equipped with 9 
a previously described [22] high-mass detector (HM1, CovalX AG, Zurich, Switzerland) were 10 
employed: 1) a Reflex III (Bruker Daltonics GmbH, Bremen, Germany), which was used for the 11 
measurements with NCoA-1 and STAT6Y, and an Axima CFR (Shimadzu/Kratos, Manchester, 12 
UK) for the measurements for BPTI and α-thrombin. Measurements were performed in the linear 13 
positive ion mode using standard instrument settings. Ionization was initiated by using a nitrogen 14 
laser (337 nm) with pulse energies slightly above the threshold for ion production. Each mass 15 
spectrum was the average of typically 100 to 200 scans obtained at random sample positions. 16 
Sinapinic acid was used as a matrix, dissolved at 10 mg/mL in water/acetonitrile/TFA 17 
(49.95/49.95/0.1, v/v/v). In the case of NCoA-1•STAT6Y, the matrix solution was mixed with 18 
the quenched and purified reaction mixture in a 1/1 (v/v) ratio. For α-thrombin•BPTI, the 19 
samples were directly mixed with the matrix in a 1/1 (v/v) ratio. 1 µL of the mixture was spotted 20 
on a stainless steel plate and allowed to dry under ambient conditions. All mass spectra were 21 
baseline-corrected and smoothed using a Savitzky-Golay algorithm. Peak integrals were 22 
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calculated by in-house developed software or OriginPro 8 (Hearne Scientific Software, Chi- 1 
cago, USA).  2 
 3 
Results and Discussion 4 
Effects of Different Binding Affinities on the Efficiency of Chemical Cross-linking 5 
In order to first evaluate whether the binding affinity has any effect on the fraction of 6 
cross-linked complex detected, the coactivator protein NCoA-1 was incubated individually with 7 
alanine or cyclohexylalanine mutants of STAT6-derived peptides with binding affinities 8 
covering three orders of magnitude. The peptides selected and the corresponding dissociation 9 
constants for the complex with the coactivator protein determined at 298 K by Seitz et al. [20] 10 
are listed in Tab. 1. Given that all mutants form 1 : 1 complexes with NCoA-1 at the same 11 
binding site and have the same amount of cross-linkable primary amino groups, this system is 12 
very well suited to study the effect of binding affinities on chemical cross-linking.  13 
Since the experiments were conducted at temperatures about T = 278 ± 3 K to avoid 14 
protein degradation, the KD values had to be adapted to the utilized reaction conditions using the 15 
integrated van`t Hoff equation (1): 16 
 ܭ஽ଶ଻଼௄ ൌ ܭ஽ଶଽ଼௄ · ݁
∆ೃಹమవఴ಼°
ೃ  ·ቀ
భ
೅ ି 
భ
మవఴ ಼ቁ                               (1) 17 
with R being the universal gas constant. For the standard reaction enthalpy ∆ோܪଶଽ଼௄° , a 18 
value of -7.63 ± 0.13 kcal mol-1 determined by ITC measurements [20] was assumed. According 19 
to thermodynamics, the equilibrium is shifted towards the product side with decreasing 20 
temperature in the case of an exothermic reaction (H < 0) and thus higher binding affinities, i.e. 21 
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lower KDs and higher complex concentrations, are expected for a reaction temperature of 278 K 1 
as compared to 298 K. The calculated values of ܭ஽ଶ଻଼௄ are listed in Tab. 1 as well. 2 
The protein-peptide complexes were chemically cross-linked with the homobifunctional 3 
cross-linker DSS for 4 h. After a quenching and purification step, the cross-linked samples were 4 
analyzed by MALDI-ToF-MS. A CovalX high mass detector was used for all experiments in 5 
order to avoid detector saturation with low mass compounds and to ensure similar detection 6 
efficiency for the entire m/z range. In comparison with mass spectra of control samples without 7 
any cross-linker, a significant amount of cross-linked protein-peptide complex with a mass of 18 8 
kDa was detected for all derivatives. In the control spectra, a peak at m/z 14800 corresponding to 9 
ionized NCoA-1 was observed (data not shown), the mass spectra of the cross-linked sample 10 
contained a slightly shifted NCoA-1 peak (due to attached cross-linker molecules whose other 11 
ends were hydrolyzed or linked intramolecularly) and a cross-linked NCoA-1•STAT6Y 12 
complex. Singly charged dimer ions of NCoA-1 were observed, but did not increase in intensity 13 
in the mass spectra for the cross-linked samples. The dimer is probably formed by nonspecific 14 
gas-phase clusters. Fig. 2a contains MALDI mass spectra of all cross-linked NCoA-1•STAT6Y 15 
complexes. In general, a fairly good correlation between the binding affinity and the amount of 16 
cross-linked complex was found. For high-affinity complexes, a high amount of cross-linked 17 
species was detected, whereas the low-affinity complexes gave only a low amount of cross-18 
linked species. Even for the complex with peptide P797A (proline substituted by alanine, ܭ஽ଶ଻଼௄ 19 
> 10 M), the chemical cross-linking procedure induced a significant amount of a protein-20 
peptide adduct and thus suggests the formation of a specifically stabilized complex. However, 21 
the specificity of the detected complexes has to be confirmed, as will be demonstrated below.  22 
11 
 
The areas of the cross-linked complexes were normalized by the total peak area of the 1 
coactivator protein, RXL = [NCoA-1•STAT6Y] / ([NCoA-1•STAT6Y] + [NCoA-1]) · 100. The 2 
fraction of cross-linked complex RXL calculated in this fashion was compared with the 3 
theoretically calculated amount of protein-peptide complex in solution Rth based on the known 4 
KD values and the protein and peptide concentrations determined by UV measurements. Rth was 5 
estimated using the following equations: The dissociation constant KD is defined as   6 
ܭ஽ ൌ  ሾ஺ሿ೐೜· ሾ஻ሿ೐೜ሾ஺•஻ሿ೐೜              (2) 7 
where [A]eq, [B]eq, and [A•B]eq are the NCoA-1, the STAT6Y and the NCoA-1•STAT6Y 8 
complex concentrations at equilibrium, respectively. Considering [A]eq = [A]0 – [A•B]eq and 9 
[B]eq = [B]0 – [A•B]eq, where [A]0 is the NCoA-1 and [B]0 the STAT6Y concentration at t = 0, 10 
the relative amount of protein-peptide complex Rth can be calculated with equation (3): 11 
ܴ௧௛ ൌ  ଵ଴଴ሾ஺ሿబ ቌ
ሾ஺ሿబାሾ஻ሿబା௄ವమళఴ಼
ଶ െ ቆ
൫ሾ஺ሿబାሾ஻ሿబା௄ವమళఴ಼൯
మ
ସ െ ሾܣሿ଴ · ሾܤሿ଴ቇ
భ
మቍ              (3) 12 
The comparison of Rth and RXL is shown in Fig. 2b. For most of the peptides, less 13 
complex was detected in comparison with the theoretical value. There can be different reasons 14 
for this behavior: 1) the protein is partially inactive and 2) the efficiency of chemical cross-15 
linking is not sufficient to stabilize all complexes present in solution. For instance, a reaction of a 16 
partially hydrolyzed cross-linker with the protein or peptide at a position close to the binding 17 
face does not yield a cross-linked complex and thus decreases the observed fraction of cross-18 
linked complex. Nevertheless, a reasonable agreement of the course of RXL as a function of KD 19 
with the course of Rth was detected.  20 
We also estimated errors bars based on the following uncertainties: for the concentration 21 
measurement by UV, the error resulting from the sum of absorbance accuracy and 22 
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reproducibility of the NanoDrop is about 10 %. Additionally, an estimated absorption coefficient 1 
ε (http://expasy.org/) was used. Although only a minimum laser power at the detection limit and 2 
a final protein concentration of 5 M was used to obtain the spectra of the control and the cross-3 
linked samples, non-specific adduct ions could not be avoided. These aggregations of 4 
simultaneously desorbed molecular species are formed as a consequence of clustering in the gas 5 
phase of the expanding desorption plume and do not reflect the binding affinities in solution. [23] 6 
For the control samples, protein-peptide adducts were observed in some cases with a relative 7 
peak intensity up to 15 % (data not shown). For the mass spectra of cross-linked samples, cross-8 
linked complexes aggregated with one or two peptides occurred from time to time (Fig. 2a). 9 
Because of this adduct formation, quantitative analysis of the fraction of cross-linked complex by 10 
MALDI-MS is slightly hampered. Based on measured standard deviations for the relative 11 
complex amount and the presence of non-specific gas-phase adducts, an error of 10 % was 12 
estimated for RXL for all peptides.  13 
The RXL values of L794A and P797A exhibited a closer match between measured and 14 
theoretical complex amounts for the mutants. Two main reasons are believed to be responsible 15 
for that: 1) The influence of unspecific adducts plays a more important role for the low-affinity 16 
complexes since the relative error for the relative complex amount is much higher than for the 17 
high-affinity complexes. 2) The peaks of the protein and the cross-linked protein-peptide 18 
complex are not perfectly resolved. Since the integration limits were chosen at the minimum 19 
intensity between these peaks, the amount of cross-linked complex is probably overestimated for 20 
the low-affinity complexes.  21 
Nevertheless, the observed correlations between the binding affinity and the amount of 22 
cross-linked complex in the present study and previous investigations led to the assumption that 23 
13 
 
chemical cross-linking in combination with MALDI-MS is a valuable tool to rank binding 1 
affinities with dissociation constants in the nanomolar and low micromolar range. 2 
 3 
Considerations on the Disturbance of the Chemical Equilibrium  4 
Preferably, a method for the analysis of protein-protein interactions would yield not only 5 
relative but also absolute complex levels to provide thermodynamic parameters such as 6 
dissociation constants. Our data revealed lower complex levels as predicted by solution phase 7 
equilibria. In another study dealing with the domain interplay of uPAR, the detected amount of 8 
cross-linked uPAR-ATF complex exceeded the level predicted from the equilibrium binding 9 
situation after 15 min cross-linking reaction at pH 7.4. [24] In contrast, Bich et al. detected for 10 
several noncovalent complexes based on the hydrophobic effect complex levels of about 90 % of 11 
the predicted values on average after chemical cross-linking with the amine reactive 12 
homobifunctional cross-linker 1,1′-(suberoyldioxy)bisazabenzotriazole (SBAT) and MALDI-MS 13 
detection. [25] The question arises whether the chemical stabilization of the noncovalent 14 
complex can disturb the solution phase equilibrium and if so, under which conditions this shift 15 
could be expected.  16 
The NHS ester does not only react with A•B, but also with the unbound A and B and thus 17 
changes the values of free [A]eq and [B]eq as well (see Scheme 1). In order to discuss potential 18 
equilibrium shifts, the following simplifications were supposed: 1) the cross-linking rates for A, 19 
B and A•B are similar and follow pseudo-first order kinetics (݇௑௅ଵ ൌ  ݇௑௅ଶ ൌ  ݇௑௅ଷ ሻ, 2) only the 20 
reaction sites close to the binding pocket with a similar  number of reactive amino acids for all 21 
binding partners is considered, and 3) hydrolysis of the second end of a cross-linker bound to 22 
free A or B is complete before an appropriate binding partner is encountered (݇௢௡ଶ ൌ 0 in 23 
14 
 
Scheme 1). Assumption 3) was confirmed with experimental data. 10 min of separated cross-1 
linking of NCoA-1 and STAT6Y before mixing were sufficient to decrease the amount of cross-2 
linked complex to a minimum after combining of the two solutions (data not shown). Based on 3 
these assumptions, the numerator of equation (2), i.e. the product of [A]eq and [B]eq, would 4 
decrease faster than the denominator. According to Le Chatelier`s principle, the system would 5 
try to adjust the concentrations back to the equilibrium conditions by enhanced formation of 6 
reactants, i.e. dissociation of the complex.  7 
KD equals koff/kon, where koff and kon are the kinetic constants for dissociation and 8 
association, respectively. Consequently, high-affinity complexes should be less affected by the 9 
enhanced dissociation reaction due to their low koff, since the re-establishment of the equilibrium 10 
conditions would last longer. In the case of low-affinity complexes, the high koff values would 11 
allow a fast dissociation reaction and thus a lower fraction of cross-linked complex would be 12 
detected compared to the original equilibrium conditions. However, when using very efficient 13 
cross-linkers with cross-linking rate constants larger than koff and high cross-linker excess, this 14 
concentration shift would probably not be significant, as we suppose for our data. In order to 15 
generate cross-linked complex levels exceeding the theoretical complex amounts, low cross-16 
linker hydrolysis rates leading to ݇௢௡ଶ ൐ 0 or ݇௑௅ଷ  >> ݇௑௅ଵ , ݇௑௅ଶ  would be required. In summary, we 17 
would only expect major deviations of the detected cross-linked complex levels from the 18 
solution phase state in the case of complexes with no amino acids, which are reactive towards the 19 
cross-linker, close to the binding pocket, high complex dissociation rates or special reaction 20 
conditions.  21 
Consequently, the highest agreement with solution phase levels is assumed to occur for 22 
extremely efficient cross-linkers with higher reaction speed, higher reactivity towards different 23 
15 
 
amino acids and sufficient compatibility with MALDI-MS. These requirements would be 1 
fulfilled with the recently introduced homobifunctional cross-linker 1,1′-2 
(suberoyldioxy)bisazabenzotriazole (SBAT). [26] SBAT showed comparably high specificity as 3 
DSS for the cross-linking of glutathione-S-transferase (GST) dimer at 5 μM concentration in the 4 
presence of 3-fold molar excess of bovine ubiquitin. 5 
 6 
Specificity as a Function of Concentration  7 
Since the cross-linker reacts simply with reactive amino acid side chains in close 8 
proximity and does not differentiate whether the reaction partners are participants in a specific 9 
noncovalent interaction, nonspecific cross-linking of proteins is possible. As the concentrations 10 
of the biomolecules increase, the probability of a cross-linking reaction between two non-binding 11 
molecules increases.  12 
In order to prove that the observed cross-linked species of NCoA-1•STAT6Y is a specific 13 
complex and to investigate the concentration range of this specificity, three different peptide 14 
mutants were chosen and their reaction behavior with the chemical cross-linker DSS investigated 15 
for three different concentrations. The relative amount of cross-linked complex was determined 16 
as described above and compared with the theoretical values. The resulting concentration 17 
dependence is depicted in Fig. 3. Again, a fairly good correlation between measured and 18 
theoretical values was observed. As expected, P797A having the lowest affinity showed a 19 
slightly lower ratio of experimental vs. theoretical complex amounts, since the actual  ܭ஽ଶ଻଼௄ 20 
exceeds the value of 10 μM assumed for the calculations. We suppose that with increasing 21 
concentration the amount of cross-linked species that represent nonspecific interactions 22 
increases. However, the slope of the measured values is (within error bars) not significantly 23 
16 
 
larger than the slope of the theoretical values. Thus, the amount of nonspecifically cross-linked 1 
species can be neglected and the specificity of chemical cross-linking can be extended to a 2 
concentration of 15 μM for this system.  3 
Negative Control Experiments with a Non-Binding Peptide 4 
As negative control experiment, the reaction behavior of the cross-linker and NCoA-1 in 5 
the presence of a non-binding peptide was tested as well. Oxidized insulin chain A was selected 6 
as a reference compound, since its molecular weight and thus probably its diffusion coefficient is 7 
quite similar to that of the mutated peptides of STAT6Y. Mixtures of protein and peptide in a 8 
1 : 1 molar ratio were subjected to chemical cross-linking and analyzed by MALDI-MS. As 9 
illustrated in Fig. 4, no significant amount of a cross-linked complex between the coactivator 10 
protein and the insulin peptide was observed. Visible adduct peaks have about the same intensity 11 
as in the control spectra (shown in grey). Even at higher protein and peptide concentrations (35 12 
M), no significant amount of cross-linked was detected. Consequently, chemical cross-linking 13 
requires a specific interaction between the coactivator protein NCoA-1 and a peptide. No 14 
unspecific cross-linking occurred under the described reaction conditions.  15 
 16 
Cross-linking of Weak Complexes 17 
As discussed above, a noncovalent complex of NCoA-1•STAT6Y with ܭ஽ଶଽ଼௄> 25 μM 18 
could be chemically stabilized and detected by MALDI-MS with no indication on nonspecific 19 
cross-linking. However, in a number of cellular processes even weaker complexes are involved. 20 
Physiologically relevant interactions as weak as KD  10-4 to 10-3 M are largely overseen by most 21 
analytical techniques such as ITC, X-Ray crystallography or SPR. One approach to detect such 22 
fragile complexes is NMR, as reviewed in reference [2]. In order to test whether chemical cross-23 
17 
 
linking with MALDI-MS could be used to specifically detect weak protein-protein interactions, 1 
experiments with the weak α-thrombin•BPTI complex were conducted. BPTI (m/z 6500) binding 2 
to α-thrombin (m/z 36000) is dependent on the sodium ion concentrations, which affect the 3 
conformational state of α-thrombin. [27] Whereas a concentration of 150 mM NaCl yields a KD 4 
of 100 μM, the dissociation constant decreases to 320 μM when 5 mM NaCl with 145 mM 5 
tetramethylammonium chloride (TMACl) are present in the buffer (10 mM Tris/HCl with 0.1 % 6 
PEG 6000 at pH 8 in both cases). [21]  7 
In order to detect a significant amount of protein complex, a relatively high excess of 8 
BPTI is necessary. Since Rth and RXL are relative measures related to the total amount of α-9 
thrombin in solution, the absolute concentration of α-thrombin has little influence on both R 10 
values. In contrast, variations of the BPTI concentration cause a significant variation of R. For 11 
KD = 320 μM, Rth is about 5 % for 20 μM BPTI concentration, whereas at 100 μM concentration 12 
a relative amount of α-thrombin•BPTI of 23 % is expected. An α-thrombin concentration of 13 
about 23 μM was chosen to reduce the risk of signal suppression for α-thrombin related signals. 14 
Surprisingly, few unspecific gase-phase adducts were observed in the MALDI mass spectra for 15 
the conditions chosen, which simplified spectra interpretation significantly. Cross-linking 16 
experiments were first performed at different BPTI concentrations ranging from 20 to 100 μM in 17 
10 mM Na2HPO4/NaH2PO4 at pH 8.0 with no additional salt. Significant amounts of cross-linked 18 
α-thrombin•BPTI were detected above 40 μM. Cross-linking times of 4 h at room temperature 19 
yielded RXL values of about 50 % of Rth (data not shown). For longer reaction times of 24 h, RXL 20 
even exceeded Rth by 100 % indicating unspecific complex formation for BPTI concentrations of 21 
40 and 60 μM (for higher concentrations spectra quality decreased dramatically after 24 h cross-22 
linking due to the higher concentration of cross-linker present in solution). With the addition of 23 
18 
 
150 mM NaCl or 145 mM TMACl with 5 mM NaCl to the buffer, no significant changes of RXL 1 
were observed within error. All the described results indicate that at concentrations above 40 2 
μM, nonspecific cross-linking is favored. Additionally, control experiments with the same BPTI 3 
concentrations but no α-thrombin present in solution yielded cross-linked BPTI dimers, trimers 4 
and tetramers after 24 h of cross-linking, whose extent could be correlated with the BPTI 5 
concentration. In summary, chemical cross-linking in combination with MALDI-MS is 6 
unsuitable for weak complexes with the experimental procedure described above.  7 
 8 
Conclusions 9 
The observed correlation between the binding affinity and the fraction of cross-linked complex 10 
in the mid-affinity range leads to the suggestion to use chemical cross-linking in combination 11 
with MALDI-MS to rank binding affinities. Specific complex detection could be proved up to 12 
protein and peptide concentrations of 35 μM. However, for low-affinity complexes with a KD 13 
range of 10-4 μM, a simple protocol including a cross-linking step and subsequent direct analysis 14 
with MALDI-MS cannot be applied and more sophisticated sample preparation is necessary.   15 
 16 
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Captions 
 
Fig. 1: Ribbon diagram of the NCoA-1•STAT6 complex (PDB ID code 1OJ5). Potentially cross-
linkable lysines close to the binding site are highlighted for the helical STAT6-peptide 
(light grey ribbon, L795-E808) and the protein NCoA-1 (dark grey ribbon, V259-E367). 
Additionally, the N-terminus of the linear peptide Stat6Y (L794-G814) would be well 
within in reach of a cross-linker linked to K271.  
21 
 
Fig. 2: a) Effects of binding affinity on the relative amount of cross-linked protein-peptide 
complex as determined with MALDI-MS after cross-linking; b) Comparison with 
theoretically calculated values for the solution phase equilibrium based on ܭ஽ଶ଻଼௄ values 
specified in Tab. 1. For the calculations, a dissociation constant of ܭ஽ଶ଻଼௄  = 10 μM was 
assumed for the peptide P797A. For RXL, y error bars correspond to an estimated error of 
R = 10 %, and x error bars were calculated assuming cNCoA-1 = cStat6Y = 5 ± 0.5 μM. The 
error of Rth is shown as light grey curve.    
Fig. 3: Effects of NCoA-1•STAT6Y concentrations on the amount of cross-linked complex 
detected by MALDI-MS for the peptides P797A (ܭ஽ଶ଻଼௄ > 10 ± 1 μM), P796A 
(ܭ஽ଶ଻଼௄ = 0.15  0.39 μM), L794A (ܭ஽ଶ଻଼௄ = 5.3  1.7  μM):  Comparison  of  relative 
amounts of cross-linked complex RXL derived from the MALDI mass spectra of the 
reaction mixtures (light grey columns) with theoretically calculated values for the 
solution phase equilibrium based on ܭ஽ଶ଻଼௄ (dark grey columns). The concentrations 
given on the top correspond to the resulting protein concentration in the equimolar 
protein-peptide mixture. For RXL, the absolute error R = 10 % was estimated. Error 
bars for Rth were calculated with the Gaussian law of errors.  
Fig. 4: Effects of NCoA-1 concentrations on the amount of cross-linked complex detected by 
MALDI-MS for the non-binding peptide oxidized insulin chain A. The grey curves 
(displaced for better visualization) correspond to the MALDI mass spectra of control 
mixtures without any cross-linker. The black curves are the MALDI mass spectra of the 
reaction mixture containing a 50-fold molar excess of cross-linker. No cross-link between 
NCoA-1 and the insulin peptide was observed after an incubation time of 4 h. 
22 
 
Scheme 1: Simplified scheme of reactions occurring during cross-linking of a protein-peptide 
complex; kXL designates the global kinetic constants of the reactions with the cross-
linking agent. kon indicates an association reaction and koff the dissociation of the 
noncovalent complex.  
 
 
 
Tables 
 
Table 1: Selected STAT6Y mutants and corresponding binding affinities with NCoA-1 
Name Sequence Mw exact KD in μM (298 K)a KD in μM (278 K)b 
L806Cha LLPPTEQDLTKLChaLEGQGESGY 2440.27 0.03  0.015 0.01  0.38 
Q800A LLPPTEADLTKLLLEGQGESGY 2343.22 0.11  0.02 0.04  0.38 
P796A LLAPTEQDLTKLLLEGQGESGY 2374.23 0.39  0.04 0.15  0.39 
L805A LLPPTEQDLTKALLEGQGESGY 2358.20 3.44  0.2 1.36  0.65 
L794A ALPPTEQDLTKLLLEGQGESGY 2358.20 13.3  0.6 5.3  1.7 
P797A LLPATEQDLTKLLLEGQGESGY 2374.23 > 25 > 10  1 
Mutated amino acids are marked in bold. The peptide names correspond to the mutated amino acid. The 
normal amino acid code is used; Cha = L-Cyclohexylalanine. a KD values at 298 K were taken from reference 
[20]. b KD values at 278 K were calculated using the van`t Hoff equation and thermodynamic data from [20]. 
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